Cassava Sciences Responds To Media Reports; Says ‘In November 2021, Cassava Sciences previously disclosed that certain government agencies had asked for corporate information and at that time, the media widely reported on these prior disclosures.’
- In November 2021, Cassava Sciences previously disclosed that certain government agencies had asked for corporate information and at that time, the media widely reported on these prior disclosures.
- No
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
‘Potential fabrication in research images threatens key theory of Alzheimer’s disease’ -Science.org Report
https://www.science.org/content/article/potential-fabrication-research-images-threatens-key-theory-alzheimers-disease
Pain Therapeutics, Inc. (Now Cassava Sciences) Granted U.S. Patent #11,385,221 Alzheimer’s disease assay in a living patient
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=4315&f=G&l=50&d=PTXT&p=87&S1=20220712&OS=20220712&RS=20220712